OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
April 01, 2017
A case study reviews the reformulation and scale up of high drug load prototype using wet granulation process for a model formulation.
March 28, 2017
RSSL has added new equipment for measuring the surface area of powder particles, which is important for determining the performance of excipients and APIs.
March 27, 2017
The company has secured an additional facility in Hampton, Middlesex, as part of a project to expand its UK-based operations by 15% in 2017.
March 24, 2017
The agency is recommending the suspension of a variety of medications because of unreliable bioequivalence studies conducted by Micro Therapeutic Research Labs
March 17, 2017
Caladrius is selling the remaining percentage of the subsidiary in order to focus on cell therapy development.
March 02, 2017
A robust quality agreement and good communication scheme can help avoid and alleviate regulatory concerns.
Moving global manufacturing operations may be more complicated than it appears.
Pharmaceutical Technology asked Siegfried Schmitt, principal consultant at PAREXEL, about the importance of quality agreements in the sponsor/contractor relationship.
March 01, 2017
The article reviews strategies for firms with or without existing in-house capacities and the pros and cons for outsourcing bio/pharmaceutical development and manufacturing.
This article reviews experiences with the outcome of in-house audits, audits by third parties, and purchased audit reports.